These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 8601050

  • 1. Disease-modifying antirheumatic drugs. Potential effects in older patients.
    Gardner G, Furst DE.
    Drugs Aging; 1995 Dec; 7(6):420-37. PubMed ID: 8601050
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Disease-modifying antirheumatic drugs, including methotrexate, gold, sulfasalazine, antimalarials, and D-penicillamine.
    Conaghan PG, Brooks P.
    Curr Opin Rheumatol; 1996 May; 8(3):176-82. PubMed ID: 8796975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient.
    Ranganath VK, Furst DE.
    Clin Geriatr Med; 2005 Aug; 21(3):649-69, viii. PubMed ID: 15911212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH, Whelton A.
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.
    Dale J, Alcorn N, Capell H, Madhok R.
    Nat Clin Pract Rheumatol; 2007 Aug; 3(8):450-8; quiz, following 478. PubMed ID: 17664952
    [Abstract] [Full Text] [Related]

  • 14. Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.
    McConkey B.
    Curr Opin Rheumatol; 1991 Jun; 3(3):348-54. PubMed ID: 1679342
    [Abstract] [Full Text] [Related]

  • 15. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR, Mikuls TR, Taylor TH, Ahluwalia V, Brophy M, Warren SR, Lew RA, Cannella AC, Kunkel G, Phibbs CS, Anis AH, Leatherman S, Keystone E, CSP 551 RACAT Investigators.
    N Engl J Med; 2013 Jul 25; 369(4):307-18. PubMed ID: 23755969
    [Abstract] [Full Text] [Related]

  • 16. Disease-modifying antirheumatic drugs.
    Li E, Brooks P, Conaghan PG.
    Curr Opin Rheumatol; 1998 May 25; 10(3):159-68. PubMed ID: 9608316
    [Abstract] [Full Text] [Related]

  • 17. Disease-modifying antirheumatic drugs, including methotrexate, sulfasalazine, gold, antimalarials, and D-penicillamine.
    Conaghan PG, Brooks P.
    Curr Opin Rheumatol; 1993 May 25; 5(3):276-81. PubMed ID: 8099805
    [Abstract] [Full Text] [Related]

  • 18. Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs.
    Case JP.
    Am J Ther; 2001 May 25; 8(2):123-43. PubMed ID: 11304666
    [Abstract] [Full Text] [Related]

  • 19. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
    Simon LS.
    Int J Clin Pract; 2000 May 25; 54(4):243-9. PubMed ID: 10912314
    [Abstract] [Full Text] [Related]

  • 20. Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.
    Sparks JA, Krumme AA, Shrank WH, Matlin OS, Brill G, Pezalla EJ, Choudhry NK, Solomon DH.
    Arthritis Rheumatol; 2016 Jul 25; 68(7):1588-95. PubMed ID: 26866506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.